We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...

Key Takeaways The S&P 500 edged 0.2% higher on Tuesday, March 25, 2025, despite a report showing that consumer confidence ...

We recently published a list of 12 Incredibly Cheap Dividend Stocks to Buy Now. In this article, we are going to take a look ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) and reminds investors of the April 14, ...

Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") of a class action securities lawsuit.

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Merck & Co. is flexing its pharmaceutical muscles with strong dividend growth, steady cash flow, and a blockbuster cancer ...

This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth ...

Tuesday afternoon saw the Dow lose 260 pts or 0.6%, the S&P down 61 pts or 1.1%, the Nasdaq choked – giving up 305 pts or 1.7 ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...